Charles Hooper - Apr 14, 2023 - Winnipeg, Manitoba

"Charles Hooper worked for Merck when Ivermectin was first released. He explains that in a pandemic, repurposed drugs are important due to the long timeline for development of new drugs. Charles decided to study Ivermectin at the beginning of the pandemic. He reanalyzed 95 clinical studies involving 27 countries and 134,554 patients confirming decreased death (51%), mechanical ventilation, ICU admission and improved recovery.

For the complete witness testimony, transcript, exhibits and more, please visit https://nationalcitizensinquiry.ca/witness/charles-hooper

Testimony Code: 2304WPG210

To view the complete library of Hearings, Witness Testimony, Transcripts and exhibits, visit the NCI website:
https://nationalcitizensinquiry.ca

Follow all the NCI on these channels:

NCI on X:
https://twitter.com/NCICanada

NCI on Librti:
https://librti.com/NCICanada

NCI Rumble
https://rumble.com/user/ncicanada

NCI Channels on Rumble
https://rumble.com/user/ncicanada/channels

NCI on Telegram
https://t.me/NCICanada

NCI on Facebook
https://www.facebook.com/NationalCitizensInquiryCanada

NCI on Instagram
https://www.instagram.com/ncicanada

NCI on TikTok
https://www.tiktok.com/@nci.canada

NCI on YouTube
https://www.youtube.com/@ncicanada

NCI on Odysee
https://odysee.com/@NCICanada

NCI Official Website:
https://nationalcitizensinquiry.ca

NCI Newsletter Signup:
https://nationalcitizensinquiry.ca/signup

NCI Petition:
https://nationalcitizensinquiry.ca/petition

NCI Donations:
https://nationalcitizensinquiry.ca/donate

NCI Social Media:
https://nationalcitizensinquiry.ca/social

NCI Media Inquiries:
https://nationalcitizensinquiry.ca/media-inquiries"